- Home
- LENZ vs DLY Comparison
LENZ vs DLY Comparison
Compare LENZ & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- DLY
- Stock Information
- Founded
- LENZ 2019
- DLY 2019
- Country
- LENZ United States
- DLY United States
- Employees
- LENZ N/A
- DLY N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- DLY Investment Managers
- Sector
- LENZ Health Care
- DLY Finance
- Exchange
- LENZ Nasdaq
- DLY Nasdaq
- Market Cap
- LENZ 664.5M
- DLY 787.5M
- IPO Year
- LENZ 2021
- DLY N/A
- Fundamental
- Price
- LENZ $24.67
- DLY $16.01
- Analyst Decision
- LENZ Strong Buy
- DLY
- Analyst Count
- LENZ 6
- DLY 0
- Target Price
- LENZ $35.40
- DLY N/A
- AVG Volume (30 Days)
- LENZ 168.0K
- DLY 215.9K
- Earning Date
- LENZ 08-14-2024
- DLY 01-01-0001
- Dividend Yield
- LENZ N/A
- DLY 8.93%
- EPS Growth
- LENZ N/A
- DLY N/A
- EPS
- LENZ N/A
- DLY N/A
- Revenue
- LENZ N/A
- DLY N/A
- Revenue This Year
- LENZ N/A
- DLY N/A
- Revenue Next Year
- LENZ N/A
- DLY N/A
- P/E Ratio
- LENZ N/A
- DLY N/A
- Revenue Growth
- LENZ N/A
- DLY N/A
- 52 Week Low
- LENZ $2.01
- DLY $13.26
- 52 Week High
- LENZ $31.00
- DLY $15.95
- Technical
- Relative Strength Index (RSI)
- LENZ 50.64
- DLY 29.32
- Support Level
- LENZ $25.13
- DLY $16.46
- Resistance Level
- LENZ $31.00
- DLY $16.60
- Average True Range (ATR)
- LENZ 2.09
- DLY 0.14
- MACD
- LENZ 0.15
- DLY -0.06
- Stochastic Oscillator
- LENZ 26.31
- DLY 11.76
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest
DoubleLine Yield Opportunities Fund is organized as a non-diversified, limited-term, closed-end management investment company. The Fund's investment objective is to seek a high level of total return, with an emphasis on current income.